Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00134134
Status:
COMPLETED
Last Update Posted:
2006-09-11
First Post:
2005-08-23
Brief Title:
Efficacy and Safety of Efalizumab in the Treatment of Moderate-Severe Hydradenitis Suppurativa
Sponsor:
NYU Langone Health
Organization:
NYU Langone Health
Organization Data
Organization:
NYU Langone Health
Class:
OTHER
Study ID:
H12452-01B
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
NYU Langone Health
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Genentech Inc | INDUSTRY |